Clinical Trial: Comparative Effectiveness of Dapagliflozin, Metformin, and Lifestyle Modification for Antipsychotic-Induced Weight Gain: An Open-Label Pragmatic Trial

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342764) titled 'Comparative Effectiveness of Dapagliflozin, Metformin, and Lifestyle Modification for Antipsychotic-Induced Weight Gain: An Open-Label Pragmatic Trial' on Jan. 06.

Brief Summary: Clinical trial:

The goal of this clinical trial is to learn if dapagliflozin can help reduce weight gain caused by antipsychotic medications in people with schizophrenia and related disorders. It will also assess the safety of dapagliflozin.

* The main questions it aims to answer are:

* Does dapagliflozin lower body weight compared to metformin or lifestyle changes alone?

* Does it improve blood sugar, cholesterol, and overall health?

* Researchers wil...